[HTML][HTML] Face-to-face and digital multidomain lifestyle interventions to enhance cognitive reserve and reduce risk of Alzheimer's disease and related dementias: a …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - Nutrients, 2019 - mdpi.com
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - …, 2019 - search.ebscohost.com
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

Face-to-face and digital multidomain lifestyle interventions to enhance cognitive reserve and reduce risk of Alzheimer's disease and related dementias: a review of …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - 2019 - cabidigitallibrary.org
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - Nutrients, 2019 - search.proquest.com
interventional studies were required to contain 3 or more separate active lifestyle behavior
components.[...] the intensity, frequency, and duration of intervention implementation in …

Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - Nutrients, 2019 - europepmc.org
Background Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

[HTML][HTML] Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - mdpi.com
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

[HTML][HTML] Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - Nutrients, 2019 - ncbi.nlm.nih.gov
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A …

NT Bott, A Hall, EN Madero, JM Glenn… - …, 2019 - pubmed.ncbi.nlm.nih.gov
Background Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

[PDF][PDF] Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - scienceopen.com
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …

[PDF][PDF] Face-to-Face and Digital Multidomain Lifestyle Interventions to Enhance Cognitive Reserve and Reduce Risk of Alzheimer's Disease and Related Dementias: A …

NT Bott, A Hall, EN Madero, JM Glenn, N Fuseya… - pdfs.semanticscholar.org
Background: Currently, there is no pharmaceutical intervention to treat or delay pathological
cognitive decline or Alzheimer's disease and related dementias (ADRD). Multidomain …